Get started
Live feed
·
ANALYSTRatingvia Quantisnow
Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharma downgraded by Robert W. Baird with a new price target

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Ultragenyx Pharmaceutical Inc. logo
RARE
Ultragenyx Pharmaceutical Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2014
Follow RAREFull RARE profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RARE (Ultragenyx Pharmaceutical Inc.) and more on Quantisnow.